WMWM
GILD icon

Whitaker-Myers Wealth Managers’s Gilead Sciences GILD Stock Holding History

Whitaker-Myers Wealth Managers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.31M Buy
18,284
+3,890
+27% +$513K 0.39% 45
2026
Q1 		$2.01M Buy
+14,394
New +$2.02M 0.4% 46

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Whitaker-Myers Wealth Managers's GILD Position: Q2 2026 in Review

Whitaker-Myers Wealth Managers increased its Gilead Sciences (GILD) stake by 27% in Q2 2026, buying an estimated $513K and bringing the position to 18,284 shares worth $2.31M. The position accounts for 0.39% of the portfolio, ranked #45.

Whitaker-Myers Wealth Managers first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Whitaker-Myers Wealth Managers held 18,284 shares of Gilead Sciences worth $2.31M as of Q2 2026.
  • Whitaker-Myers Wealth Managers bought 3,890 Gilead Sciences shares in Q2 2026, an estimated $513K.
  • Gilead Sciences made up 0.39% of Whitaker-Myers Wealth Managers's portfolio in Q2 2026, its #45 holding.
  • Whitaker-Myers Wealth Managers first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Whitaker-Myers Wealth Managers's 13F filing for Q2 2026, filed 9 Jul 2026.